Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study
about
Azathioprine for multiple sclerosisIncidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritisIncreased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurineHow should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancerRheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary studyNon-Hodgkin's lymphoma in rheumatoid arthritis.Rheumatological manifestations of haematological diseases.Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study.Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritisSystemic lupus erythematosus: review of synthetic drugs.Do inflammatory bowel disease therapies cause cancer?Estimated radiation exposure from medical imaging in hemodialysis patientsThe validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28Risk of cancer among rheumatoid arthritis patients in California.Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate.Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.Immune disorders and susceptibility to neoplasmsAre patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies.Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications.Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment.Efficacy and safety of drugs for ulcerative colitis.Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.TNF-α inhibitors: are they carcinogenic?Lymphoma in inflammatory bowel disease and treatment decisions.Malignancy as a comorbidity in rheumatic diseases.No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan.Systemic lupus erythematosus and the risk of malignancy.Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study.Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: a retrospective cohort study.Coexistent malignant conditions in rheumatoid arthritis - A population-based cross-sectional study.Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee.
P2860
Q24242945-F77484C8-B02B-4FF7-9DAD-8EF29ECC3A98Q24675306-E41FE05B-D986-44BA-B7F4-B35E1CDD5CACQ24685403-872157C8-80C5-4B19-83CB-6A7F0A397703Q26777409-CFC7337E-1D5D-419D-930A-AC66E4D2620CQ28346582-A32EE7A3-A19E-43C0-892B-F334CB8EF20EQ33224257-D63DAC74-A1B7-47D2-B763-F51F713815CAQ33362177-CE631B55-3009-441F-B7CF-70576796B69AQ33563567-856B87EC-E167-46DE-9BD1-C48C8A072BE6Q33578386-31889D6F-A26A-4825-A05F-E2C66B502698Q33937936-03876465-6BD3-4A3E-A3BC-ED80A6A1F950Q34078707-2BD78DFD-77B6-4FC8-891F-F6BE76001E1CQ34352780-D5C74B4C-B74E-4B4E-AAAC-827EDBAFA5E9Q34376405-6DF2471B-B7A5-4837-997D-3CA6CF7BE64EQ34498515-3B90680D-7656-41E2-95EE-52D4174AEB11Q34613890-AEF923A6-7534-4975-93E4-B3F1DE3BC188Q34695442-8FC93FAC-17B4-4A86-8542-366B4B7B1D6DQ34897125-76CD44E8-98DD-4C65-9CEC-2D23640B644CQ35162890-2EA9E2ED-F13C-48E8-88EC-A7F8736B6A98Q35547060-0C74F53A-446C-409E-A397-79C8274592E5Q35555473-74C81A96-B114-4B59-B89C-FACCA00C28F7Q35555527-6FFE22E4-622D-4DCE-BA09-28EF6351A826Q36101742-69991B12-0FE6-45F7-ADE0-F3187B1A5510Q36964382-01901874-AB43-48D0-92D0-157C27FAC07CQ36975701-BD04610E-DD8D-4473-A8D2-0F62AAC4E652Q37205246-D114607D-F2D2-4569-8EA2-7A8C229CB00AQ37345896-6F212C45-F7CF-4053-AAC1-F2378F499705Q37358453-9D4A57D7-A27D-4CC5-9823-52113339FA4AQ37404886-57726A96-76AA-4D98-BFEA-5BA2B10D7446Q37727232-009F5C8B-9698-45BC-B7F2-5E468CEC3FE7Q37798091-A21F06DD-A462-41E6-9D47-CF6CA16BEBAAQ37893973-8A42B4F1-E24B-4754-A477-E400DE79474EQ38024070-0898130F-6C0C-4FDA-9B2C-C9761CDF07FFQ38029322-1071797E-10B7-4198-A3C7-B76240823CAAQ38421453-A890653F-4233-4DAB-BAA4-5F95A561FFF6Q38492864-93D29F82-CD34-4873-A753-3650CC175BDFQ38645434-C283CFC2-0B6F-40A0-879F-FF213D1293E6Q39137571-309CA4BC-1EDA-4111-A4BE-254F1E216E81Q40354684-6E589ED1-2D17-4517-9CD3-4C3CA8AD147AQ40754916-DDFF9318-49E2-4719-9776-8DF4200B55FCQ41132142-3A173F79-9D36-4721-9082-FAE4A8472264
P2860
Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study
description
1988 nî lūn-bûn
@nan
1988 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Lymphoproliferative cancer and ...... ine: a 20 year follow up study
@ast
Lymphoproliferative cancer and ...... ine: a 20 year follow up study
@en
Lymphoproliferative cancer and ...... ne: a 20 year follow up study.
@nl
type
label
Lymphoproliferative cancer and ...... ine: a 20 year follow up study
@ast
Lymphoproliferative cancer and ...... ine: a 20 year follow up study
@en
Lymphoproliferative cancer and ...... ne: a 20 year follow up study.
@nl
prefLabel
Lymphoproliferative cancer and ...... ine: a 20 year follow up study
@ast
Lymphoproliferative cancer and ...... ine: a 20 year follow up study
@en
Lymphoproliferative cancer and ...... ne: a 20 year follow up study.
@nl
P2093
P2860
P356
P1476
Lymphoproliferative cancer and ...... ine: a 20 year follow up study
@en
P2093
P2860
P304
P356
10.1136/ARD.47.12.988
P407
P577
1988-12-01T00:00:00Z